Enrico Ferrero

1 ta ish

GlaxoSmithKline (United Kingdom)

1. Opportunities and obstacles for deep learning in biology and medicine

   Travers Ching, Daniel Himmelstein, Brett K. Beaulieu‐Jones +33

   Sharh maqola20184 iqtibos

   ABIABI:AkademIndex/2026.other.303358